Their aim was to capture two different human breast cancer cell lines (MCF-7 ~ 15–17 μm [106] and MDA-MB-231 ~ 12 μm [107]) from blood cells through specific conjunction of Epithelial Cell Adhesion Molecule (EpCAM) to magnetic nanoparticles. Here, EPCAM is linked to breast carcinoma.